Steve Jobs Cancer

January 17, 2011 by staff 

Steve Jobs Cancer, Steve Jobs, chairman of the board of Apple Computer, looks at the new “Macintosh” personal comptuer following the shareholder meeting January 24, 1984 in Cupertino, California. The Macintosh, then the price of 2495 and represents a challenge for IBM in the PC market
In honor of Dr. Martin Luther King, Jr. U.S. markets are closed today. However, futures happen. Today’s news is the size of the announcement by Apple (NASDAQ: AAPL) CEO Steve Jobs that takes leave of the company. Mr. Jobs, whose return in the mid-90s helped rocket Tech Company in one of the largest company in the world, is considered a major force in Apple. Without his continuous guidance, investors are worried about continued growth. Mr. Jobs is a survivor of pancreatic cancer, and had a liver transplant two years ago.
Apple Inc. CEO Steve Jobs, who took a day off in the face of medical risks and potential complications for the rest of his life after undergoing a liver transplant two years ago.

Surgery can result in “countless” difficulties later than patients undergoing drug treatment and face possible organ rejection, “said Linda Sher, a physician at the University of Southern California Liver Transplant Program in Los Angeles. Jobs also said he was treated for a neuroendocrine tumor. That cancer is known to breed and spread to the liver, “said John Fung, chairman of the Institute of Digestive Diseases at the Cleveland Clinic in Cleveland, Ohio.

“The number of complications that may occur are from here to heaven,” Sher, a surgeon at the program, said today in a telephone interview. “I could spend all day to list.”

Neuroendocrine tumors strike about 3,000 Americans a year. This type of malignant tumor grows and spreads slowly, and in some patients; tumor migration is not detected until years after the disease is detected, Fung said in a telephone interview.

Report to Team

Please feel free to send if you have any questions regarding this post , you can contact on

Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.


Comments are closed.